Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Zealand Pharma

< Previous 1 2 3 4 5 6 Next >
News headline image
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma – Notification of holding of treasury shares
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma Announces Financial Results for the First Half of 2026
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
From Zealand Pharma
Via GlobeNewswire
News headline image
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
From Zealand Pharma
Via GlobeNewswire
News headline image
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity
From Zealand Pharma
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback